NCT05879926 2026-03-03
OFSET
NRG Oncology
Phase 3 Recruiting
Clinical Trials
5 trialsNCT04567420 2025-10-16
DARE
Criterium, Inc.
Phase 2 Recruiting
NCT06914440 2025-07-15
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Xijing Hospital
Phase 2 Recruiting
NCT06476119 2025-04-23
OPTImaL
The Netherlands Cancer Institute
Recruiting
NCT05296746 2025-03-18
RIBOLARIS
SOLTI Breast Cancer Research Group
Phase 2 Recruiting